Skip to Main Content

Paper Details

Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury.
PLoS One
1
2022
APOL1, APOL1 protein, APOL1 variants, APOL1-G1, APOL1-associated kidney, albumin promoter, apolipoprotein L1, human, humans, kidney cells, kidney damage, kidney disease, kidney injury, mice, mouse, participants, plasma, plasma APOL1, podocyte, podocytes, renal disease, risk variants
Author NameAffiliation
Ian H de BoerUniversity of Washington
Ian H de BoerKidney Research Institute, University of Washington
Ian H de BoerUniversity of Washington
Ian H de BoerKidney Research Institute, University of Washington
Jonathan HimmelfarbUniversity of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
Jonathan HimmelfarbUniversity of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
Bryan KestenbaumUniversity of Washington
Bryan KestenbaumKidney Research Institute, University of Washington
Stephen M HewittCenter for Cancer Research
Stephen M HewittCenter for Cancer Research
Avi Z RosenbergJohns Hopkins Medical Institutions
Avi Z RosenbergJohns Hopkins Medical Institutions
Jeffrey B KoppNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
Andrew N HoofnagleUniversity of Washington
Andrew N HoofnagleUniversity of Washington
Andrew N HoofnagleKidney Research Institute, University of Washington
  • 1 - 18

Datasets

Release 1.2